SFS — Revumenib Eligibility Detection System Class II

FDA Device Classification

Classification Details

Product Code
SFS
Device Class
Class II
Regulation Number
864.1885
Submission Type
Review Panel
PA
Medical Specialty
Hematology
Implant
No

Definition

A revumenib eligibility detection system is identified as a prescription in vitro diagnostic device intended for the qualitative detection of structural abnormalities of chromosome 11 in specimens from patients with acute leukemia for the purpose of identifying patients who may benefit from treatment with revumenib, in accordance with the approved therapeutic product labeling.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
DEN240067cytocell limitedKMT2A Breakapart FISH Probe Kit PDx (CDA-LPH013)September 19, 2025